Chief Physician, Doctor of Medicine, and Principal Investigator. Graduated from Central South University and received systematic training in radiation therapy at well-known oncology specialty hospitals in Chengdu, Beijing, and Guangzhou.
hinews.cn A Blood Test Predicts “Dementia”
Haiba News Predicting “Dementia” in Advance, Hainan Chengmei Hospital Introduces P-tau217 Blood Testing Technology
People's Daily Online Hainan Cancer HospitalThe True “Face” of the Hidden “Killer” of Women’s Health
Haiba News Unveiling Ovarian Cancer——An Exclusive Interview with Director Cao Aie of the Department of Gynecology, Hainan Cancer Hospital
Hainan Daily Why is It Mostly in the Late Stage When Discovered? Unveiling the Mystery of the “Queen of Gynecological Cancers”
hinews.cn The Hidden “Killer” of Women’s Health
Haikou Net Experts from Hainan Cancer Hospital Reveal the True Face of the Hidden “Killer” of Women’s Health
Phoenix News The Hidden “Killer” of Women’s Health
Haikou Net Hainan’s first case! A woman suffered from hydronephrosis for 7 years. This doctor’s technique brought relief.
www.ehnjk.com Hainan Cancer Hospital introduces new stent, cracks the malignant ureteral obstruction treatment dilemma.
Chief Physician
She specializes in radiation therapy for head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, nasal sinuses, and esophagus), breast cancer, and gastrointestinal malignancies (such as liver cancer, pancreatic cancer, gastric cancer, rectal cancer, cancer of the pancreatic head, and gallbladder cancer). Also proficient in treating urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, and kidney cancer), pediatric tumors, soft tissue sarcomas, thoracic tumors, and rare tumors. Skilled in integrating advanced multimodal radiation technologies to treat complex and refractory tumors, with extensive experience in the prevention and management of complications from radiotherapy and chemotherapy.
Chief Physician, Doctor of Medicine, and Principal Investigator. Graduated from Central South University and received systematic training in radiation therapy at well-known oncology specialty hospitals in Chengdu, Beijing, and Guangzhou.
She specializes in radiation therapy for head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, nasal sinuses, and esophagus), breast cancer, and gastrointestinal malignancies (such as liver cancer, pancreatic cancer, gastric cancer, rectal cancer, cancer of the pancreatic head, and gallbladder cancer). Also proficient in treating urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, and kidney cancer), pediatric tumors, soft tissue sarcomas, thoracic tumors, and rare tumors. Skilled in integrating advanced multimodal radiation technologies to treat complex and refractory tumors, with extensive experience in the prevention and management of complications from radiotherapy and chemotherapy.
Generation and development of malignant tumors, radiation therapy and comprehensive treatment of tumors, multimodal radiotherapy for complex and refractory tumors.
Member of the Second Committee of Tumor Support Therapy Professional Committee of Chinese Anti-Cancer Association
Member of the Third Session of Radiotherapy Equipment Technology Branch of China Medical Equipment Association
Standing Member of the Seventh Committee of Radiation Oncology Therapeutics Branch of Hainan Provincial Medical Association
Member of Lung Cancer Professional Committee of Hainan Cancer Prevention and Treatment Association
Vice Chairman of the MDT Professional Committee of Hainan Cancer Prevention and Treatment Association
Standing member of the Fertility Preservation Professional Committee of the Maternal and Child Health Association of Hainan Province
Member of the First Professional Committee of Integrated Rehabilitation of Nasopharyngeal cancer of the Chinese Anti-Cancer Association
Member of the Expert Committee of the Special Skills Training Program for Precision Radiotherapy for Tumors of the Talent Exchange Service Center of the National Health and Wellness Commission (in the direction of target-area outlining)
Member of Expert Committee of Medical Quality Control Center for Radiotherapy Specialties in Hainan Province (2023.06-2024.12)
I. Proteomics analysis of G protein-coupled receptor kinase 4-inhibited cellular growth of HEK293 cells. J Proteomics. 2019; 207:103445。
II. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database,Clin Transl Oncol,2021,7。
III. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma,Int J Gen Med,2021,14: 9247—9260。
IV. Myoepithelial carcinoma of major salivary glands: Analysis ofpopulation-based clinicopathologic and prognostic features,Translational oncology 20 (2022) 101410。